The Advocate General (AG) of the Court of Justice of the European Union (CJEU), Yves Bot, has issued a stern rebuke to Spain’s legal challenges to the European Unitary Patent and Unified Patent Court, and calls for their dismissal by the Court, thus providing a good indication that the final obstacles in the way of […]
The US Supreme Court’s decision in Limelight v Akamai apparently confirms that in the US, induced infringement of a patent can only occur if the patent has been directly infringed. Akamai Technologies Inc. was the exclusive licensee of a patent for a content delivery network (CDN) process. Limelight Networks Inc. was also operating a CDN. […]
1 October 2014 sees the introduction of a number of changes to design and copyright law as the Intellectual Property Act 2014 comes into force. The most noteworthy of these changes is the introduction of criminal sanctions for copying registered designs, to deter flagrant copying. Also of particular importance is the change to the provisions […]
We are pleased to announce that as of 18 August 2014, we will have an office in Munich with a senior Partner working there permanently. This move will allow us to further improve our services for UK and international clients seeking patent protection in Germany and across Europe. The move has been made possible by […]
In good news for the agrochemical industry, the Court of Justice of the European Union (CJEU) has ruled that agrochemical safeners are eligible for Supplementary Protection Certificates (SPCs). Regulatory authorisation is required before certain products, such as pharmaceuticals and agrochemicals, can be launched on the market. Authorisation can take several years, and so may significantly […]
Judgment was handed down on 15 May 2014 in the long running patent dispute between Actavis and Eli Lilly (Lilly) with respect to Lilly’s patent relating to the use of the anti-cancer drug pemetrexed disodium (Alimta®). Claim 1 defines a use of the drug with vitamin B12. In the first case of its kind, Actavis […]